Langendorff - perfused 토끼 하트의 Multiparametric 광 매핑

Executive Industry Relevance

Optical mapping in Langendorff-perfused rabbit hearts enables high-resolution, artifact-free visualization of cardiac electrophysiology, supporting mechanistic de-risking in arrhythmia target validation. This approach provides quantitative spatial-temporal data on action potentials and calcium transients, directly informing predictive confidence in preclinical models of ventricular and atrial arrhythmias. The method bridges discovery biology and translational research by enabling reproducible, scalable assessment of pro-arrhythmic liability and therapeutic response in a disease-relevant system.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Interrogates therapeutic hypotheses by mapping reentrant wave dynamics and phase singularities during induced arrhythmias.
• Operational Value: Enables functional target validation through simultaneous voltage and calcium imaging to de-risk excitation-contraction coupling mechanisms.
• Predictive Value: Supports portfolio triage by quantifying arrhythmogenic substrate vulnerability under controlled perfusion conditions.

Screening & Assay Development

• Scientific Value: Prepares validated biological systems for downstream workflows by establishing baseline electrophysiological and calcium handling phenotypes.
• Operational Value: Addresses assay standardization and reproducibility through Langendorff perfusion control and dye-staining protocols.
• Scalability: Highlights screening readiness via panoramic and dual imaging systems capable of simultaneous multi-site optical recording.

Translational & Preclinical Research

• Disease Relevance: Uses rabbit heart model with demonstrated similarity to human excitation-contraction coupling and arrhythmia wave patterns.
• Translational Continuity: Connects discovery findings to preclinical validation through quantitative analysis of conduction, repolarization, and calcium handling during regular rhythm and arrhythmia.
• Risk-Adjusted Advancement: Supports go/no-go decisions by providing mechanistic insights into arrhythmia induction, maintenance, and termination.

Pipeline & Workflow Integration

The method fits within the discovery continuum from target validation through lead identification to preclinical assessment, enabling iterative refinement of antiarrhythmic candidates based on electrophysiological and calcium handling profiles.

• Discovery Biology: Supports hypothesis testing and pathway clarification by visualizing rotor dynamics and action potential calcium transient relationships during arrhythmogenesis.
• Screening: Describes assay readiness through reproducible optical signal acquisition with sufficient signal-to-noise ratio for spatial-temporal analysis.
• Analytics: Highlights quantitative measurements of excitation and repolarization dynamics, enabling comparative condition assessment.
• Translational Research: Connects method to preclinical continuity via disease-relevant arrhythmia models and calcium handling insights relevant to heart failure and metabolic disease.
• Enterprise Reuse: Frames the optical mapping system as a reusable platform for assessing multiple compounds or genetic modifications in a standardized perfused heart preparation.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in arrhythmia mechanisms.
• Operational Value: Standardization, reproducibility, and scalability of electrophysiological and calcium transient measurements.
• Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk in cardiovascular programs.
• Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on quantitative arrhythmia liability data.

Implementation Considerations

• Requires expertise in cardiac isolation, Langendorff perfusion, and fluorescent dye handling.
• Needs optical mapping systems with photo diode arrays or CMOS cameras, light sources, and perfusion pressure control.
• Demands cross-team standardization of staining protocols, excitation-contraction uncoupling, and signal acquisition parameters.
• Involves adaptation considerations for species-specific flow rates, optics, and dye loading when extending beyond rabbit hearts.
• Includes practical limitations such as dye photobleaching, motion artifact susceptibility, and the need for precise temperature and pH maintenance during experiments.

Biopharma FAQs